A detailed history of Nbc Securities, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 460 shares of BIIB stock, worth $72,634. This represents 0.01% of its overall portfolio holdings.

Number of Shares
460
Previous 750 38.67%
Holding current value
$72,634
Previous $173,000 48.55%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$189.07 - $236.8 $54,830 - $68,672
-290 Reduced 38.67%
460 $89,000
Q2 2024

Jul 10, 2024

BUY
$190.52 - $236.72 $7,620 - $9,468
40 Added 5.63%
750 $173,000
Q1 2024

Apr 05, 2024

BUY
$212.02 - $267.71 $19,717 - $24,897
93 Added 15.07%
710 $153,000
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $42,069 - $50,640
189 Added 44.16%
617 $159,000
Q3 2023

Nov 03, 2023

BUY
$253.3 - $285.89 $108,412 - $122,360
428 New
428 $110,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.